v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Jun. 30, 2022
Current assets:    
Cash $ 220,412 $ 280,877
Accounts receivable (net of allowance of $0 and $0, respectively) 130,397 93,674
Inventory 433,188 331,531
Other current asset 106,745 137,797
Total current assets 890,742 843,879
Total assets 890,742 843,879
Current liabilities:    
Accounts payable 434,446 234,152
Accrued expense - related party 9,000
Convertible notes payable - net of discounts 535,895 344,151
Note payable, net of discount 358,905  
Stock payable 4,041
Total current liabilities 1,342,287 578,303
Commitments and contingencies
Stockholders’ equity:    
Series A Preferred Stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of September 30, 2022 and June 30, 2021, respectively) 1 1
Series B Preferred Stock, ($0.001 par value, 5,000 shares authorized, and 2,450 and 3,260 issued and outstanding as of September 30, 2022 and June 30, 20221, respectively) 2 3
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 95,964,484 issued and outstanding as of September 30, 2022 and 91,814,484 issued and outstanding as of June 30, 2022, respectively) 95,964 91,814
Additional paid in capital 29,100,518 28,275,216
Accumulated deficit (29,648,030) (28,101,458)
Total Stockholders’ Equity (451,545) 265,576
Total Liabilities and Stockholders’ Equity $ 890,742 $ 843,879

Source